Advertisement
Screener

XBIOTECH INC. (XBIT) Increase (Decrease) in Deferred Revenue

2.8 / 5 stars · 68/120 Roast Me

XBIOTECH INC. Increase (Decrease) in Deferred Revenue

XBIOTECH INC. (XBIT) reported Increase (Decrease) in Deferred Revenue of $0 for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2022-05-10

  • XBIOTECH INC. increase (decrease) in deferred revenue for the quarter ending 2022-03-31 was $0.00.
  • XBIOTECH INC. increase (decrease) in deferred revenue for the quarter ending 2021-06-30 was $0.00.
  • XBIOTECH INC. increase (decrease) in deferred revenue for the quarter ending 2021-03-31 was $0.00.
  • XBIOTECH INC. increase (decrease) in deferred revenue for the quarter ending 2020-09-30 was -$1.50M.
Period endIncrease (Decrease) in Deferred Revenue 3 monthIncrease (Decrease) in Deferred Revenue 6 monthIncrease (Decrease) in Deferred Revenue 9 month
2022-03-31$0.00
10-Q · filed 2022-05-10
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
$0.00
10-Q · filed 2021-08-09
2021-03-31$0.00
10-Q · filed 2022-05-10
2020-09-30-$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
2020-06-30$1.50M
10-Q · filed 2021-08-09
2019-06-30$0.00
10-Q · filed 2020-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
HYPERION DEFI, INC. (HYPD)United States$0.065B
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95